External agentia for treating osteoproliferation

Abstract

The invention provides external agentia for treating osteoproliferation. The external agentia is Chinese patent medicine external powder and tincture for treating the osteoproliferation, is developed for many years, and is composed of Chinese azalea flowers, pyrola, red flowers, hindu datura flowers, lumbricus, sangusis draconis, ligusticum wallichii, rhizoma drynariae, garden balsam, barks of himalayan coralbean, pawpaws, eucommia ulmoides, Chinese ivy, caulis spatholobi, angelica sinensis, turmeric, roots of common peony, musk and camphor after verification of clinical experiments. The external agentia is clear in treatment rule of the whole prescription and reasonable in compatibility of medicines, has the functions of relieving exterior syndrome and dispelling cold, dispelling wind and eliminating dampness, dispersing blood stasis and dredging collateral, and treats osteoproliferation, the curative effect is good, the effect is achieved fast, use is convenient, safety and reliability are achieved, the effective rate reaches 100 percent, the effect of treating both symptoms and root causes can be achieved, and the aim of being not prone to relapse after curing can be achieved.

Description

Technical field: [0001] The invention relates to an external powder and tincture of a Chinese patent medicine for treating hyperosteogeny. Background technique: [0002] Osteoarthritis is also called bone spur, osteoarthritis, also known as proliferative arthritis, osteoarthritis, hypertrophic arthritis, senile arthritis, degenerative joint disease, etc. [0003] Osteoarthritis, the cause of the disease is that due to changes in the cartilage, intervertebral discs, ligaments and other soft tissues that make up the human joints, degeneration, bone spurs on the joint edges, periosteum hypertrophy and other changes, bone destruction occurs, resulting in secondary osteoarthritis. Hyperplasia, leading to joint deformation, when walking or bearing weight, causing joint pain, and limited mobility and other symptoms of a series of diseases. [0004] There are two stages in the development of osteoproliferative disease. The first stage is the disease period, and the second stage is ...

AI Technical Summary

Problems solved by technology

[0006] Some existing drugs for the treatment of hyperosteogeny have one or another deficiency and cannot achieve the effect of treating both symptoms and root causes